Taiwan draws foreign biotech IPOs


Vibrant scene: Taiwan is home to the largest number of listed biotechnology companies in Asia with the sector expanding due to a well-educated workforce, historic appetite for high-tech industries and government support. – AFP

Singapore firm working on experimental cancer drugs plans listing by end-May

HONG KONG: A Singaporean biotechnology company working on experimental cancer drugs is listing in Taiwan, potentially opening the door for more foreign peers to go public on the island.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Business , IPO , cancer , drugs , Taiwan

Next In Business News

Alibaba, Abu Dhabi back AI startup MiniMax’s IPO
Foreign investors dump bonds amid rupee slide
NCT Alliance gets nod for acquisition
Beijing issues early 2026 investment plan�
Nor Zahidi continues as MPC member
Stronger outlook for card payments until 2029
Fini boss forecasts huge increase in nickel demand
Johor data centre water demand to accelerate
Official reserve assets total US$124bil, says BNM
KKR bid to take Yomeishu private is derailed by top shareholder

Others Also Read